168 related articles for article (PubMed ID: 33627107)
1. Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk.
Velez G; Nguyen HV; Chemudupati T; Ludwig CA; Toral M; Reddy S; Mruthyunjaya P; Mahajan VB
Mol Cancer; 2021 Feb; 20(1):39. PubMed ID: 33627107
[No Abstract] [Full Text] [Related]
2. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
Seider MI; Mruthyunjaya P
Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
[TBL] [Abstract][Full Text] [Related]
3. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
[TBL] [Abstract][Full Text] [Related]
4. Proteomics in uveal melanoma.
Heiferman MJ; Mahajan VB; Mruthyunjaya P
Curr Opin Ophthalmol; 2022 May; 33(3):202-210. PubMed ID: 35102096
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in uveal melanoma.
Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
[TBL] [Abstract][Full Text] [Related]
6. iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors.
Crabb JW; Hu B; Crabb JS; Triozzi P; Saunthararajah Y; Tubbs R; Singh AD
PLoS One; 2015; 10(8):e0135543. PubMed ID: 26305875
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.
Glasgow BJ; McCannel TA
Am J Ophthalmol; 2018 May; 189():122-126. PubMed ID: 29530782
[TBL] [Abstract][Full Text] [Related]
8. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.
Chang SH; Worley LA; Onken MD; Harbour JW
Melanoma Res; 2008 Jun; 18(3):191-200. PubMed ID: 18477893
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
[TBL] [Abstract][Full Text] [Related]
10. Liquid biomarkers in melanoma: detection and discovery.
Lim SY; Lee JH; Diefenbach RJ; Kefford RF; Rizos H
Mol Cancer; 2018 Jan; 17(1):8. PubMed ID: 29343260
[TBL] [Abstract][Full Text] [Related]
11. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
12. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers.
Velez G; Wolf J; Dufour A; Mruthyunjaya P; Mahajan VB
Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):14. PubMed ID: 37955612
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
14. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.
Lin Z; Süsskind D
J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679
[TBL] [Abstract][Full Text] [Related]
15. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.
Berry D; Seider M; Stinnett S; Mruthyunjaya P; Schefler AC;
Retina; 2019 Jun; 39(6):1154-1164. PubMed ID: 29578940
[TBL] [Abstract][Full Text] [Related]
16. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
17. [Melanoma inhibitory activity (MIA). Evaluation of a new tumor-associated antigen as a serum marker for uveal melanomas].
Schaller UC; Mueller AJ; Bosserhoff AK; Haraida S; Löhrs U; Buettner R; Kampik A
Ophthalmologe; 2000 Jun; 97(6):429-32. PubMed ID: 10916387
[TBL] [Abstract][Full Text] [Related]
18. Proteomics in uveal melanoma.
Missotten GS; Beijnen JH; Keunen JE; Bonfrer JM
Melanoma Res; 2003 Dec; 13(6):627-9. PubMed ID: 14646627
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma.
Lorenzo D; Ochoa M; Piulats JM; Gutiérrez C; Arias L; Català J; Grau M; Peñafiel J; Cobos E; Garcia-Bru P; Rubio MJ; Padrón-Pérez N; Dias B; Pera J; Caminal JM
Cancer Res Treat; 2018 Oct; 50(4):1130-1139. PubMed ID: 29198096
[TBL] [Abstract][Full Text] [Related]
20. The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment.
Babchia N; Landreville S; Clément B; Coulouarn C; Mouriaux F
Exp Eye Res; 2019 Apr; 181():213-222. PubMed ID: 30771295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
